---
title: "Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280987228.md"
description: "Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure"
datetime: "2026-03-30T09:10:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280987228.md)
  - [en](https://longbridge.com/en/news/280987228.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280987228.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280987228.md) | [繁體中文](https://longbridge.com/zh-HK/news/280987228.md)


# Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure

Sino Biopharmaceutical Completes Hygieia Acquisition With Performance-Linked Payout Structure

### 相关股票

- [Guotai SSE STAR Brand Name Drug ETF (589720.CN)](https://longbridge.com/zh-CN/quote/589720.CN.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-CN/quote/510660.CN.md)
- [Dacheng CSI All Share Health Care Equipment and Services ETF (516610.CN)](https://longbridge.com/zh-CN/quote/516610.CN.md)
- [ICBCCS SSE STAR Biology and Medicine ETF (588860.CN)](https://longbridge.com/zh-CN/quote/588860.CN.md)
- [Tianhong CNI BIOMEDICINE ETF (159859.CN)](https://longbridge.com/zh-CN/quote/159859.CN.md)
- [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-CN/quote/159316.CN.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-CN/quote/512010.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-CN/quote/159849.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-CN/quote/516500.CN.md)
- [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-CN/quote/520690.CN.md)
- [SBP GROUP (01177.HK)](https://longbridge.com/zh-CN/quote/01177.HK.md)
- [SIHUAN PHARM PREF OFFER (44080.HK)](https://longbridge.com/zh-CN/quote/44080.HK.md)
- [Penghua SSE STAR Biology and Medicine ETF (588250.CN)](https://longbridge.com/zh-CN/quote/588250.CN.md)
- [Founder Fubon CSI Medicine and Medical Device Innovation ETF (560600.CN)](https://longbridge.com/zh-CN/quote/560600.CN.md)
- [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-CN/quote/520880.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-CN/quote/159837.CN.md)
- [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/zh-CN/quote/516820.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-CN/quote/516930.CN.md)
- [Huaan Hang Seng Biotech ETF (159102.CN)](https://longbridge.com/zh-CN/quote/159102.CN.md)
- [China Universal 800 Health Care ETF (159929.CN)](https://longbridge.com/zh-CN/quote/159929.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-CN/quote/512290.CN.md)
- [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/zh-CN/quote/159506.CN.md)
- [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/zh-CN/quote/159992.CN.md)

## 相关资讯与研究

- [Biocytogen and Sihuan partner to advance new therapeutics for weight loss](https://longbridge.com/zh-CN/news/281501537.md)
- [RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial](https://longbridge.com/zh-CN/news/281458440.md)
- [Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase](https://longbridge.com/zh-CN/news/281231901.md)
- [CICC Remains a Buy on Yonghe Medical Group Co., Ltd. (2279)](https://longbridge.com/zh-CN/news/281703443.md)
- [Annovis Bio Director Purchased Shares Worth Over $1.4M](https://longbridge.com/zh-CN/news/281662341.md)